Literature DB >> 25555837

Reliability and validity of the EQ-5D-5L compared to the EQ-5D-3L in patients with osteoarthritis referred for hip and knee replacement.

Barbara L Conner-Spady1, Deborah A Marshall, Eric Bohm, Michael J Dunbar, Lynda Loucks, Ammar Al Khudairy, Tom W Noseworthy.   

Abstract

PURPOSE: To assess the test-retest reliability of the EQ-5D-5L (5L) and compare the validity of the 5L and EQ-5D-3L (3L) in osteoarthritis patients referred to an orthopaedic surgeon for total joint replacement.
METHODS: We mailed questionnaires to 306 consecutive patients following referral and a second questionnaire after 2 weeks to assess reliability. Questionnaires included the 5L, EQ-VAS, Short Form-12, Oxford hip and knee scores, pain VAS, and the 3L. We compared the ceiling effect, redistribution properties, convergent and discriminant validity, and discriminatory power of the 5L and 3L.
RESULTS: We obtained 176 respondents (response rate 58 %), 60 % female, 64 % knee patients, mean age 65 years (SD 11), with no significant differences between responders versus non-responders. Intraclass correlation coefficients were 0.61-0.77 for the 5L dimensions and 0.87 for the 5L index. For the 3L, most patients used level 2 (some/moderate problems) for mobility (87 %), usual activities (78 %), and pain/discomfort (71 %). In comparison, 5L responses were spread out with only 52, 42, and 50 %, respectively, using the middle level. All convergent validity coefficients were stronger with the 5L (Spearman coefficients 0.51-0.75). Absolute informativity (Shannon's index) showed higher results for all dimensions of the 5L compared with the 3L (average difference 0.74). Relative informativity (Shannon's evenness index) showed an increase from the 3L to the 5L in mobility, usual activities, and pain/discomfort.
CONCLUSIONS: The 5L provided stronger validity evidence than the 3L, especially for dimensions relevant to this patient population-mobility, usual activities, and pain/discomfort.

Entities:  

Mesh:

Year:  2015        PMID: 25555837     DOI: 10.1007/s11136-014-0910-6

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  39 in total

1.  Comparison of the EQ-5D and SF-12 health surveys in a general population survey in Alberta, Canada.

Authors:  J A Johnson; A S Pickard
Journal:  Med Care       Date:  2000-01       Impact factor: 2.983

Review 2.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

3.  Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients.

Authors:  A Simon Pickard; Maria C De Leon; Thomas Kohlmann; David Cella; Sarah Rosenbloom
Journal:  Med Care       Date:  2007-03       Impact factor: 2.983

4.  The use of the Oxford hip and knee scores.

Authors:  D W Murray; R Fitzpatrick; K Rogers; H Pandit; D J Beard; A J Carr; J Dawson
Journal:  J Bone Joint Surg Br       Date:  2007-08

5.  Reliability and validity of the EuroQol in patients with osteoarthritis of the knee.

Authors:  M Fransen; J Edmonds
Journal:  Rheumatology (Oxford)       Date:  1999-09       Impact factor: 7.580

6.  Psychometric properties of the EQ-5D-5L in the general population of South Korea.

Authors:  Tae Hyup Kim; Min-Woo Jo; Sang-il Lee; Seon Ha Kim; Son Mi Chung
Journal:  Qual Life Res       Date:  2012-12-06       Impact factor: 4.147

7.  Patient-reported outcome in total hip replacement. A comparison of five instruments of health status.

Authors:  M Ostendorf; H F van Stel; E Buskens; A J P Schrijvers; L N Marting; A J Verbout; W J A Dhert
Journal:  J Bone Joint Surg Br       Date:  2004-08

8.  Understanding the pain experience in hip and knee osteoarthritis--an OARSI/OMERACT initiative.

Authors:  G A Hawker; L Stewart; M R French; J Cibere; J M Jordan; L March; M Suarez-Almazor; R Gooberman-Hill
Journal:  Osteoarthritis Cartilage       Date:  2008-03-04       Impact factor: 6.576

9.  Evaluating change using patient-reported outcome measures in knee replacement: the complementary nature of the EQ-5D index and VAS scores.

Authors:  Fang-Ju Lin; Jennifer Samp; Alexis Munoz; Pei Shieen Wong; A Simon Pickard
Journal:  Eur J Health Econ       Date:  2013-06-14

10.  Quality of life profile and psychometric properties of the EQ-5D-5L in HIV/AIDS patients.

Authors:  Bach Xuan Tran; Arto Ohinmaa; Long Thanh Nguyen
Journal:  Health Qual Life Outcomes       Date:  2012-11-01       Impact factor: 3.186

View more
  58 in total

1.  An EQ-5D-5L value set based on Uruguayan population preferences.

Authors:  Federico Augustovski; Lucila Rey-Ares; Vilma Irazola; Osvaldo Ulises Garay; Oscar Gianneo; Graciela Fernández; Marcelo Morales; Luz Gibbons; Juan Manuel Ramos-Goñi
Journal:  Qual Life Res       Date:  2015-08-05       Impact factor: 4.147

2.  The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.

Authors:  Xuejing Jin; Fatima Al Sayah; Arto Ohinmaa; Deborah A Marshall; Christopher Smith; Jeffrey A Johnson
Journal:  Clin Orthop Relat Res       Date:  2019-07       Impact factor: 4.176

3.  Clinical improvement and satisfaction after total joint replacement: a prospective 12-month evaluation on the patients' perspective.

Authors:  Florian D Naal; Franco M Impellizzeri; Ulrich Lenze; Vanessa Wellauer; Rüdiger von Eisenhart-Rothe; Michael Leunig
Journal:  Qual Life Res       Date:  2015-06-12       Impact factor: 4.147

4.  Mapping Between the Sydney Asthma Quality of Life Questionnaire (AQLQ-S) and Five Multi-Attribute Utility Instruments (MAUIs).

Authors:  Billingsley Kaambwa; Gang Chen; Julie Ratcliffe; Angelo Iezzi; Aimee Maxwell; Jeff Richardson
Journal:  Pharmacoeconomics       Date:  2017-01       Impact factor: 4.981

5.  Comparing the validity and responsiveness of the EQ-5D-5L to the Oxford hip and knee scores and SF-12 in osteoarthritis patients 1 year following total joint replacement.

Authors:  Barbara L Conner-Spady; Deborah A Marshall; Eric Bohm; Michael J Dunbar; Tom W Noseworthy
Journal:  Qual Life Res       Date:  2018-02-08       Impact factor: 4.147

6.  Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients.

Authors:  Adrienn Katalin Poór; Fanni Rencz; Valentin Brodszky; László Gulácsi; Zsuzsanna Beretzky; Bernadett Hidvégi; Péter Holló; Sarolta Kárpáti; Márta Péntek
Journal:  Qual Life Res       Date:  2017-09-05       Impact factor: 4.147

7.  An evidence-based walking program among older people with knee osteoarthritis: the PEP (participant exercise preference) pilot randomized controlled trial.

Authors:  Laurianne Loew; Lucie Brosseau; Glen P Kenny; Natalie Durand-Bush; Stéphane Poitras; Gino De Angelis; George A Wells
Journal:  Clin Rheumatol       Date:  2017-03-22       Impact factor: 2.980

8.  Psychometric evaluation of the Chinese version of the Child Health Utility 9D (CHU9D-CHN): a school-based study in China.

Authors:  Peirong Yang; Gang Chen; Peng Wang; Kejian Zhang; Feng Deng; Haifeng Yang; Guihua Zhuang
Journal:  Qual Life Res       Date:  2018-05-05       Impact factor: 4.147

9.  Psychometric properties of the EQ-5D-5L in patients with hip or knee osteoarthritis: reliability, validity and responsiveness.

Authors:  Amaia Bilbao; Lidia García-Pérez; Juan Carlos Arenaza; Isidoro García; Gloria Ariza-Cardiel; Elisa Trujillo-Martín; Maria João Forjaz; Jesús Martín-Fernández
Journal:  Qual Life Res       Date:  2018-07-05       Impact factor: 4.147

10.  EQ-5D-5L is More Responsive than EQ-5D-3L to Treatment Benefit of Cataract Surgery.

Authors:  Mihir Gandhi; Marcus Ang; Kelvin Teo; Chee Wai Wong; Yvonne Chung-Hsi Wei; Rachel Lee-Yin Tan; Mathieu F Janssen; Nan Luo
Journal:  Patient       Date:  2019-08       Impact factor: 3.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.